Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
02 1Ambiopharm, Inc.
03 1Catalent Pharma Solutions LLC
04 1FRESENIUS KABI IPSUM SRL
01 1GLUCAGON
02 2Glucagon
03 1glucagon
01 1Sweden
02 1Switzerland
03 2U.S.A
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0009
Start Marketing Date : 2005-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41524-0005
Start Marketing Date : 2012-09-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11014-0687
Start Marketing Date : 2024-01-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (3mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 66558-0195
Start Marketing Date : 2022-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Glucagon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glucagon, including repackagers and relabelers. The FDA regulates Glucagon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glucagon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glucagon manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Glucagon supplier is an individual or a company that provides Glucagon active pharmaceutical ingredient (API) or Glucagon finished formulations upon request. The Glucagon suppliers may include Glucagon API manufacturers, exporters, distributors and traders.
click here to find a list of Glucagon suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glucagon as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glucagon API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glucagon as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glucagon and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glucagon NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glucagon suppliers with NDC on PharmaCompass.
We have 4 companies offering Glucagon
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
